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Mammalian embryo comparison identifies novel pluripotency
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Tiago Faial1, Hindrik H. D. Kerstens5, Camille Bouissou2, Gregory Parsonage1,2, Kaveh Mashayekhi6,7,
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ABSTRACT
During early mammalian development, transient pools of pluripotent
cells emerge that can be immortalised upon stem cell derivation. The
pluripotent state, ‘naïve’ or ‘primed’, depends on the embryonic stage
and derivation conditions used. Here we analyse the temporal gene
expression patterns of mouse, cattle and porcine embryos at stages
that harbour different types of pluripotent cells. We document
conserved and divergent traits in gene expression, and identify
predictor genes shared across the species that are associated with
pluripotent states in vivo and in vitro. Amongst these are the
pluripotency-linked genes Klf4 and Lin28b. The novel genes
discovered include naïve- (Spic, Scpep1 and Gjb5) and primed-
associated (Sema6a and Jakmip2) genes as well as naïve to primed
transition genes (Dusp6 and Trip6). Both Gjb5 and Dusp6 play a role
in pluripotency since their knockdown results in differentiation and
downregulation of key pluripotency genes. Our interspecies comparison
revealed new insights of pluripotency, pluripotent stem cell identity
and a newmolecular criterion for distinguishing between pluripotent
states in various species, including human.
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INTRODUCTION
Understanding early embryonic development, particularly
pluripotency, is paramount for establishing pluripotent stem cell
(PSC) models. These models are powerful tools for in vitro disease
modelling as well as for improving the health of domestic species
(e.g. cattle and pig) and for the production of livestock with specific
traits through genetic engineering. For practical and ethical reasons,
most mammalian development studies have used the mouse as the
model organism. However, early mouse development diverges from
that of primates and of domestic species.
The blastocyst stage is the first key embryonic hallmark of
development and mammalian embryos at this stage look relatively
similar, i.e. embryos have an outermost layer, the trophectoderm, and
an inner layer of cells, the inner cell mass (ICM). The ICM includes
the cells that will form the primitive endoderm and the pluripotent
epiblast cells (Cockburn andRossant, 2010). Notably, mouse species
are among the fewmammals that can halt their development and enter
diapause at this stage (Renfree and Fenelon, 2017). During the next
several days, the shape and size of the embryo changes dramatically.
The epiblast cells self-organise into an epithelium shaped as a cup in
rodents, or as a flat disc in primates as well as in the pig and bovine
(ungulate species). At this stage, the embryo is composed of an
epithelial radially symmetric epiblast (ERSE)which is surrounded by
the extraembryonic endoderm. As gastrulation proceeds, epiblast
cells undergo epithelial to mesenchymal transition and migrate to
form the definitive endoderm and mesoderm germ layers. This
migration causes the embryo to elongate, generating an asymmetrical
elongated anterior to posterior epiblast (APE) (Degrelle et al., 2005;
Lawson et al., 1991; Maddox-Hyttel et al., 2003). The epiblast in
ERSE and APE stages remain pluripotent as suggested by clonal
studies performed in the mouse (Lawson et al., 1991) and by chimera
studies using mouse epiblast stem cells (mEpiSCs) (Huang et al.,
2012; Masaki et al., 2016). Despite many conserved morphological
features, the establishment of PSC cultures in vitro has proved
challenging in species other than mouse and primates.
Human and mouse pluripotent stem cells exist in two different
states that have been termed ‘naïve’ and ‘primed’ (Nichols and
Smith, 2009). mEpiSCs, conventional human embryonic stem cells
(hESCs) and induced PSCs (human-iPSCs), represent the primed
state and correspond to the post-implantation epiblast (Ng and
Surani, 2011; Chen et al., 2016). In contrast, mouse embryonic stem
cells (mESCs) and induced PSCs (mouse-iPSCs) represent the
naïve state and correspond to the E4.5 epiblast despite being derived
from ICM epiblast cells (Boroviak et al., 2014). Different methods
have been proposed to revert hESCs to a naïve state (Chan et al.,
2013; Gafni et al., 2013; Theunissen et al., 2014; Takashima et al.,
2014) or to derive naïve ESCs from human ICM cells (Guo et al.,
2016). However, only some of these naïve hPSCs have been shown
to correlate with the monkey pre-implantation epiblast stage
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Gödöll}o, Hungary. 11Departments of Equine Sciences and Farm Animal Health,
Faculty of Veterinary Medicine, Utrecht University, 3584CL Utrecht, The Netherlands.
*Joint first authors
‡Joint second authors
§Author for correspondence (andreia.bernardo@crick.ac.uk)
A.S.B., 0000-0002-5355-6657; J.C.S., 0000-0003-2413-9392
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is properly attributed.
1
© 2018. Published by The Company of Biologists Ltd | Biology Open (2018) 7, bio033282. doi:10.1242/bio.033282
B
io
lo
g
y
O
p
en
 by guest on October 21, 2018http://bio.biologists.org/Downloaded from 
mESCs and mEpiSCs have different culture requirements,
express specific gene sets and have different abilities to form
chimeras (Huang et al., 2012; Nichols and Smith, 2009; Pauklin
et al., 2011). These differences have been determined by
comparative studies performed between mESCs and mEpiSCs
and further substantiated by in-depth analysis of mouse embryonic
development (Boroviak et al., 2014). Similar analysis of marmoset
and cynomolgus monkey embryo development revealed striking
differences between these mammalian species and the mouse
(Boroviak et al., 2014; Nakamura et al., 2016). However, little is
known about the mechanisms underlying pluripotency in vivo
during early embryonic development of ungulate species from
which stem cell derivation has not been successfully achieved,
except for an isolated report on the derivation of pig mEpiSCs which
has not been validated by other labs (Alberio et al., 2010).
Molecular comparisons of pluripotent embryonic tissues between
species could provide valuable insights into disparities in the
efficacy of pluripotent stem cell derivation and the nature of the stem
cells derived. To this end, we compared the transcriptomes of
mouse (Mus musculus), pig (Sus scrofa) and bovine (Bos taurus)
ICM, ERSE and APE stage-matched embryos devoid of their
extraembryonic tissues. By focusing on gene orthologues across the
three species, we identified conserved and non-conserved gene
expression patterns between the mouse and the ungulate species.We
then intersected the set of conserved genes that were differentially
expressed between in vivo stages with those that characterised the
naïve or primed state found in mouse pluripotent cells in vitro. This
allowed us to: (1) identify a set of novel predictor genes, important
for the identity and/or maintenance of the ‘naïve’ state or the
‘primed’ state and (2) understand the evolutionary conservation of
the naïve and primed pluripotency circuitry.
RESULTS
Comparison of mouse, pig and bovine embryos reveals
different paces of development in these species
Pluripotent cells are present within the ICM, giving rise to the early
epiblast, and in the late post-implantation epiblast of the ERSE and
APE stages. To characterise these stages of pluripotency at a
molecular level we set out to compare the transcriptomes of mouse
and ungulate embryos.
Interspecies comparison studies depend on reliable stage matching
of embryos. To ensure the comparison of equivalent embryonic
stages, we first performed in situ hybridisation with Oct4 (Pou5f1),
Nanog and Sox2 probes in E3.5 (ICM stage), E6.25 (ERSE stage) and
E7.25 (APE stage) mouse embryos and in a range of pig and bovine
embryos (E4.0-E7.0 to align the ICM stage; E7.0-E16.0 to align the
ERSE stage; E12.5-E18.0 to align the APE stage). Nodal was also
used as it shows a dynamic expression during epiblast development
both in mouse and bovine embryos (Varlet et al., 1997; van Leeuwen
et al., 2014). Finally, we studied Brachyury (T ) expression in APE
stage embryos to detect the appearance of the primitive streak.
Based on Oct4/OCT4, Nanog/NANOG and Sox2/SOX2
expression in the inner layer of the newly formed blastocyst, we
found that the stage best corresponding to mouse E3.5 was at E6.5/7
in both pig and cattle. The equivalent of the mouse ERSE stage was
at E10.5 in pig and E14.0 in cattle, with OCT4 expression
demarcating a near perfect radially symmetrical epiblast, and
NANOG, SOX2 and NODAL expression demarcating the entire
epiblast but showing an asymmetric distribution within it as
previously described for the mouse [Fig. 1A; Fig. S1A-C (Varlet
et al., 1997; Avilion et al., 2003; Chambers et al., 2003)]. Finally,
we identified a characteristic asymmetric line of BRACHYURY
expression defining the APE stage of pig and bovine embryos at
E12.5 and E17.0, respectively (Fig. 1B), while OCT4, NANOG,
SOX2 andNODALwere still well expressed in the epiblast (Fig. 1A;
Fig. S1A-C).
These data defined the stages at which we compared the
transcriptome of ungulate embryos with the mouse ICM, ERSE
and APE stages (Fig. 1C).
Mouse, pig and bovine transcriptional landscapes of the
early and late epiblast cluster together
Because of the small RNA content of mammalian early embryos, we
first assessed different RNA amplification methods (Fig. S2A-D).
This analysis showed that the SMARTer method was superior to the
other methods tested. Next, ICM, ERSE and APE stage embryos
were dissected to isolate the pluripotent cell populations, RNAwas
purified and libraries were prepared. Transcriptome-wide profiling
of the libraries resulted in 76–233million reads per sample, yielding
37–168 million uniquely mappable reads (Fig. 2A; Table S1).
These were used for transcript quantification (Fig. S2E) and 3′ bias
assessment (Fig. S2F). Good coverage across the complete length of
transcripts was observed. As expected, most of the reads fell into
exons (Fig. 2A). Matched samples correlated well with each other
(Fig. 2B), however, sample pICM3 was of poor quality [Fig. S2E
and cluster analysis based on orthologue genes (data not shown)]
and was therefore omitted from differential expression analyses. The
purity of our dissected samples was confirmed by: (1) the low/
absence of trophoblast-associated gene expression in our samples
and (2) the low/absence of extraembryonic ectoderm- and
endoderm-associated gene expression in the ERSE samples (data
not shown).
The DNA sequence similarity between bovine, porcine and
mouse varies. To avoid having to discard read sequence alignments
in order to compare data across species, our analysis focused on
orthologous genes common to the three species (Table S2). In all,
11,444 1:1:1 orthologous genes (i.e. genes that have only one
counterpart in the studied species) were identified in our dataset. By
clustering the samples according to their transcriptome we found
that: (1) the samples formed three distinct clusters according to the
species; (2) ungulate samples clustered away from mouse samples;
and (3) the sample groups (per embryonic stage) could be split into
ICM and late epiblast (ERSE and APE) (Fig. 2B). This observation
was further confirmed by principal component analysis, in which
the differences between ERSE and APE samples were too small to
define distinct clusters (Fig. 2C), and is in keeping with what has
been observed in the monkey for similar staged embryos (Nakamura
et al., 2016). This analysis also highlighted that in the mouse the
difference between ICM and ERSE/APE was bigger than in bovine
or pig (Fig. 2C). In conclusion, our transcriptome-wide profiling has
yielded a robust dataset for performing inter-species comparisons.
Significant inter-species differences in core pluripotency
genes
To evaluate the conservation and divergence in gene expression of
the studied species we compared the orthologues expressed at each
embryonic stage (Fig. 3A). Between 5439 and 7543 orthologous
genes were expressed by each species at a given stage. A large
proportion of the stage-specific genes were commonly expressed
across species (up to 82% of the genes expressed by each species).
Analysis of the commonly expressed genes at each embryonic stage
using the Kyoto Encyclopaedia of Genes and Genomes (KEGG)
Pathway Database only revealed an enrichment of genes involved in
metabolism and energy, cell cycle and DNA repair (Table S3A).
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Oct4 (Pou5f1), Sox2 and Nanog are considered the core
pluripotency triad in human and mouse pluripotent cells. They also
play essential roles during early development in the mouse embryo
(Osorno and Chambers, 2011). Strikingly, the expression values
extracted from our dataset revealed that the expression of OCT4,
NANOG and SOX2 tended to be upregulated between ICM to ERSE in
ungulates, while being decreased (Nanog and Sox2) or stable (Oct4) in
mouse (Fig. 3B,C). This was confirmed by in situ hybridisation, which
also denoted a low level of NANOG and SOX2 in ungulate ICM
(Fig. 1A; Fig. S1A,B). These differences highlight nuances in gene
expression, which might reflect a divergence in the mechanisms of
pluripotency maintenance between mouse and ungulate species.
To get further insight into the mouse and ungulate pluripotency
circuitry we searched our ICM and ERSE datasets for genes known
to be involved in pluripotency (Fig. 3C; Fig. S3A and Table S3B).
In the mouse, naïve pluripotency can be maintained with LIF and
BMP signalling (Qi et al., 2004). Thus, it was surprising that the
expression of the BMP effector Smad1 was hardly detected in
mouse and pig ICM but was present in ERSE embryos. LIFR
expression, a gene upstream of the JAK/STAT pathway, was lacking
in both the bovine and porcine ICM (Fig. 3C; Fig. S3A in yellow),
suggesting that ungulate naïve pluripotency does not rely on LIF
signalling and STAT3 is likely activated through an alternate receptor
or pathway. Interleukins 6 and 11 are possible ligand candidates
since we detect expression of their receptors in both bovine and
porcine embryos. Klf4/KLF4 expression at the ICM of all species,
which in mESCs is regulated by Stat3 following activation by LIF
(Bourillot et al., 2009), further suggests that in ungulates the JAK/
STAT pathway is also activated to maintain pluripotency. Naïve
pluripotency in the mouse can also be maintained independently of
Jak/Stat3 and Bmp/Smad1 signalling through the pharmacological
inhibition of both Gsk3β (which mimics Wnt signalling) and FGF
Fig. 1. Alignment of embryo stages across species. (A) In situ hybridisation for Oct4/OCT4 in ICM, ERSE and APE stage embryos. Two to six embryos
were analysed per species and these are representative embryos. Scale bars: 100 µm. (B) In situ hybridisation for Brachyury/BRACHYURY in APE stage
embryos. Two to six embryos were analysed per species and these are representative embryos. Scale bars: 200 µm. (C) Illustration of the samples dissected
for RNA-sequencing. The epiblast is depicted in shades of pink; trophectoderm in grey; extraembryonic endoderm in light brown and extraembryonic
mesoderm in dark brown. The line in the APE stages represents the primitive streak. Dashed lines show epiblast cells dissected for total RNA isolation.
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signalling (Ying et al., 2008). Gsk3β has many targets, including
Esrrb, which is one of the main effectors through which the Gsk3/β-
catenin/Tcf3 axis modulates ESC self-renewal (Martello et al., 2012).
We found that Esrrb/ESRRB was expressed in the ICM stage of all
species, although at a considerable lower level in pig (Fig. 3C;
Table S3B) and was downregulated in ERSE. However, the terminal
target of the Wnt pathway, Tcf3, was hardly detected in the mouse
ICM and its expression was upregulated in ERSE stage embryos,
while in ungulates, TCF3 was only (lowly) expressed at the ICM
stage (Fig. 3C; Fig. S3A and Table S3B).
Altogether, our data identified conservation traits across species in
terms of the transcriptional machineries, and divergences in the
timing, level and/or pattern of gene expression. Moreover, we have
shown that there are more similarities within the ungulate embryos
Fig. 2. Transcriptional landscapes distinguish ICM from the late epiblast in both mice and ungulate species. (A) Total number of reads not mapped
uniquely and reads mapping uniquely to exonic, intronic, or intergenic regions. (B) Heatmap of Pearson correlations coefficients. The dendrograms on the
margins represent the average linkage clustering of the samples. (C) Projection of samples according to their principal components analysis. PC1, 71% of
variance explained; PC2, 16%; PC3, 4%; PC4, 2%.
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Fig. 3. Significant inter-species differences in core pluripotency genes were detected. (A) Venn diagrams showing the overlap between expressed
orthologues at each developmental stage in the three species: mouse (green), cattle (red) and pig (blue). (B) UCSC browser views of the RNA-seq coverage
plot of uniquely mapped reads for Pou5f1/POU5F1, Nanog/NANOG and Sox2/SOX2 genes in the different species and at the different stages. (C) Dot plots
showing the values of expression from the RNA-seq data of known pluripotency associated genes. I, ICM; E, ERSE; A, APE.
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than there are between ungulate andmurine embryos in terms of stage-
specific gene expression, transcript localisation in the embryo and core
pluripotency gene expression. The identified differences from mouse
pluripotent embryonic tissues likely explain, at least in part, why it has
been inefficient to derive pluripotent stem cells from ungulate species
using approaches suitable for mouse stem cell derivation.
Differential expression analysis identifies common stage-
specific pluripotency-associated genes
To further assess the degree of conservation between species, we
compared the 1:1:1 orthologues that are differentially expressed
between stages in each species (Table S4A). Each stage transition
category was plotted as a Venn diagram showing the extent of
intersection between species (Fig. 4A; Table S4B). Several hundred
genes were differentially regulated between stages in each species
(with the mouse having the highest percentage of differentially
expressed genes, Fig. 4B). However, the overlap of differential
expression between the species was quite small (Fig. 4A). In
particular, few genes were jointly up or downregulated between the
ERSE and APE stage, probably reflecting the similarity between
these stages (Fig. 2C). Nonetheless, between two species the
number of genes in the overlap for the ICM to ERSE transition was
about twice what would be expected from a random occurrence
(P<10−4, hypergeometric test; Fig. 4C). The overlap between the
Fig. 4. Differential expression analysis identifies common stage specific pluripotency-associated genes. (A) Venn diagrams showing the intersections
of differentially expressed genes during epiblast development in the three species (with q-value ≤0.25, minimum fold change 1.5). Below each Venn is shown
the list of genes belonging to the central territory of the diagram. (B) Graphs showing the proportion of differentially expressed (DE) 1:1:1 orthologues across
stages. *P<10-17, χ2 test. (C) Graphs showing the conservation of differential expression between species. The conservation is expressed as the number of
genes that are differentially expressed between stages in two or in three species, divided by the expected overlap if the same number of genes were
independently sampled from the 1-1-1 orthologues in those genomes. P-values are based on the hypergeometric distribution, **P<1E -4, *P<0.01.
6
RESEARCH ARTICLE Biology Open (2018) 7, bio033282. doi:10.1242/bio.033282
B
io
lo
g
y
O
p
en
 by guest on October 21, 2018http://bio.biologists.org/Downloaded from 
three species was even more substantial; about eight times what was
expected had it been random (P<10−4, hypergeometric test;
Fig. 4C). Overall, the overlaps for ICM to ERSE and ICM to
APE were highly significant.
We noted that most changes in gene expression between sequential
stages occur during the ICM to ERSE transition and the conserved
changes included the downregulation of a number of pluripotency-
associated genes whose expression is lower in mEpiSCs than in
mESCs, including Klf4/KLF4, Klf5/KLF5 and Pecam1/PECAM1
(Fig. 4A). Tfcp2l1, a target of Stat3 that promotes self-renewal in
mESCs (Ye et al., 2013), and Spic, a member of the Ets-family
expressed and required at the ICM stage in the mouse (Kageyama
et al., 2006; Pelton et al., 2002), were also downregulated during the
ICM-ERSE transition in all three species (Fig. 4A). The naïve
pluripotency gene Tbx3, of which expression is downregulated
between mESCs and mEpiSCs (Russell et al., 2015), was also
downregulated during the ICM-ERSE transition, albeit in mouse the
downregulation was not significant (Table S4). Moreover, some
known mouse hypoblast markers including Scd4/SCD4, Gata6/
GATA6, and Pdgfra/PDGFRa (Artus et al., 2010; Chazaud et al.,
2006; Kurimoto et al., 2006) were also downregulated across the three
species during the ICM-ERSE transition (Fig. 4A). Conversely, other
pluripotency associated genes such as Eras/ERAS (Takahashi et al.,
2003) and Lin28b/LIN28B (Darr and Benvenisty, 2009) were
upregulated in ERSE or APE stage embryos, respectively (Fig. 4A;
Fig. S4, respectively).
Together, our analysis identified a small set of genes whose
differential expression is conserved within the three species.
Comparison of in vivo and in vitro transcriptomes unveils
novel stage-specific pluripotency-associated genes
Many developmentally important genes are conserved throughout
evolution and here we have found that the expression of a small pool
of highly conserved genes characteristically changes during the ICM
to late epiblast (ERSE and APE) transition. As some of these genes
were not previously recognised as being associated with
pluripotency, we asked whether they are also differentially
expressed in the naïve and primed pluripotency states of mouse
pluripotent cell lines. To this end, we compared our RNA-sequencing
dataset with published data for mESCs (Marks et al., 2012) and
mEpiSCs (Veillard et al., 2014). We used data for mESCs grown in
serum+Lif (BMP dependent), or in 2i+Lif (ERK/GSK3 inhibition
dependent), where cells remain in a naïve state of pluripotency.
Correlation analysis of mouse in vivo and in vitro samples showed
that the ICM stage did not correlate well with any pluripotent cells
whereas both ERSE and APE had some similarities with serum-
mESCs and mEpiSCs (Fig. S5A). Principal component analysis
performed using the three species samples further confirmed these
findings (Fig. S5B); i.e. by plotting the samples on PC5, which
separates the samples according to their developmental position. It
is clear that while ERSE/APE stage embryos group well with late
epiblast derived stem cells (mEpiSCs), ICM stage embryos do not
group with any of the ICM-derived stem cells (2i-mESCs or serum-
mESCs), although they are slightly closer to 2i-mESCs (Fig. S5B).
This is in keeping with previous findings that show that naïve
mESCs resemble the pre-implantation E4.5 mouse epiblast rather
than the ICM (Chen et al., 2016; Boroviak et al., 2014), while
mEpiSCs resemble the post-implantation epiblast (Chen et al.,
2016; Kojima et al., 2014). Note that PC5 only explains 3% of the
variation in the data, while PC1-PC4 correspond to species
differences as well as in vivo/in vitro differences and do not
explain the biology of the samples.
To investigate how the mouse PSC lines compare with their
in vivo equivalents, we determined the changes occurring during the
2i-ESC to serum-ESC to mEpiSC transitions and cross-compared
this datasets with our previous in vivo analysis (Table S5A). The
overlap of differentially expressed genes between in vivo and
in vitro mouse samples suggests that the 2i- to serum-mESC
transition reflects the ICM-ERSE transition better than the serum-
mESCs to mEpiSCs transition, especially for the upregulated genes
(Fig. 5A). This is even clearer when the in vivo/in vitro comparison
is done with the pool of genes that are conserved across species
(Fig. 5A, right), highlighting the relevance of the conserved genes
for pluripotency. The intersection of stage-specific conserved genes
with the in vitro samples further showed that only a few genes are up
or downregulated both in vivo and in vitro (Fig. 5B; Fig. S5C and
Table S5B). These intersections also highlight that some mEpiSC-
associated genes are already upregulated in serum-mESCs (29 out
of the 44 genes upregulated between 2i-mESCs and mEpiSCs are
also upregulated between 2i- and serum-mESCs, Table S5B) while
various 2i-mESC-associated genes are significantly decreased in
serum-mESCs (10 out of the 16 genes downregulated between
2i-mESCs and mEpiSCs are already downregulated between 2i- and
serum-mESCs, Table S5B). As such, serum-mESCs can be
considered as a transitional stage between naïve and primed
pluripotency, which is in keeping with what has recently been
reported (Chen et al., 2016).
Together these analyses revealed that despite the differences
between ICM and ICM-derived cell lines, the transition between
early and late epiblast in vivo is recapitulated in vitro and reflected
by a small group of conserved genes. Surprisingly, only a few of
these have been previously associated with pluripotency.
Validation of newly discovered genes’ expression in vivo
It is likely that the genes which show significant changes in
expression both in vitro (in mouse pluripotent cells) and in vivo (in
the three species) have important conserved roles in the modulation
of pluripotency. To validate whether these genes are indeed
expressed in vitro and in vivo we selected a set of genes
associated with either the naïve/ICM state (Klf4/KLF4, Gjb5/
GJB5, Spic/SPIC, Scpep1/SCPEP1 and Psap/PSAP) or the primed/
ERSE/APE state (Trip6/TRIP6, Dusp6/DUSP6, Jakmip2/
JAKMIP2, Lin28b/LIN28b, Lpar4/LPAR4, Car14/CAR14 and Fst/
FST). We further included Sema6A/SEMA6A, which was
upregulated in the 2i-mESC to mEpiSC transition as well as in
the ICM to ERSE transition in both cow and pig but not mouse, as
SEMA6A has been shown to be important for self-renewal in hESCs
(Dowell et al., 2014). The expression levels of the selected genes in
our sequenced in vivo data are shown in Figs S5D and S6A.
We first validated the expression of these genes in embryonic
tissues by analysing blastocyst (ICM stage) and dissected epiblasts
at ERSE and APE stage embryos of the three species. Real-time
qPCR analysis of murine, bovine and porcine embryos revealed that
the levels of Spic/SPIC, Gjb5/GJB5, Scpep1/SCPEP1 and Psap/
PSAP expression were significantly higher in ICM stage embryos
than in ERSE or APE stage embryos (Fig. 5C). The same was true
for Klf4/KLF4 in the mouse and bovine but unexpectedly, this gene
was not detected in porcine embryos despite its presence in the
associated sequencing data (Figs 5C, 3C). The opposite trend,
i.e. higher expression in ERSE/APE, was confirmed for Trip6/
TRIP6, Dusp6/DUSP6, Lin28b/LIN28B, Jakmip2/JAKMIP2, and
Sema6a/SEMA6A expression (Fig. 5C) as well as for Lpar4, Car14
and Fst in the mouse (Fig. S5E). Immunostaining was then
performed for Klf4, Gjb5, Trip6 and Sema6A on mouse embryos at
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Fig. 5. See next page for legend.
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the ICM and ERSE stage. Klf4 and Trip6 are nuclear proteins,
whereas Gjb5 and Sema6A are trans-membrane proteins. ICM cells
clearly expressed both Gjb5 and Klf4, whereas these proteins
became undetectable in the epiblast at the ERSE stage (Fig. 5D;
Fig. S5F). Conversely, Sema6A expression was weak in the ICM
cells, and high in the ERSE stage epiblast (Fig. 5D). The only
discrepancy with the RNA-Seq data regarded Trip6 expression,
which was present at seemingly similar levels at both stages
(Fig. 5D), unlike what we observed by QPCR (Fig. 5C).
In summary, we largely confirmed in vivo the expression
trends highlighted by our transcriptome analysis for the
sets of genes analysed. In most cases, we also detected the
corresponding change at protein level. Thus, our interspecies
approach highlighted embryonic stage specific characteristics not
previously known.
Newly discovered genes can be used as predictors of the
naïve/primed pluripotency state
We next asked if these genes could be used as ‘predictors’ of the
naïve/primed pluripotency state in vitro or as mESC ‘differentiator’
genes, i.e. genes which could distinguish between ground state 2i-
mESCs and serum-mESCs.
Real-time qPCR was performed in mESCs (grown in 2i or
serum), mEpiSCs and, for comparative purposes, in other embryo-
derived stem cell lines, i.e. trophoblast (mTSCs) and primitive
endoderm (mXENCs) stem cells (Fig. 6A; Fig. S6B). As predicted,
Klf4, Gjb5, Scpep1 and Psap were expressed at significantly higher
levels in mESCs than in mEpiSCs and were thus considered as
predictors of the naïve state. These genes were also expressed at
considerably high levels in mTSCs and/or mXENCs. Interestingly,
Spic was the only gene which expression was restricted to 2i-
mESCs, hence a new marker of ground state of pluripotency.
Conversely, Lin28b, Sema6a, Jakmip2 and Car14 were highly
expressed in mEpiSCs compared to mESCs. Expression of Dusp6
(Fig. 6A), Fst and Lpar4 (Fig. S6B) was strongly upregulated in
serum-mESCs and in EpiSCs (Fst) or even more upregulated in
EpiSCs (Dusp6 and Lpar4). Low expression of these genes could
therefore be considered as a feature of the naïve state. Lastly, Trip6
expression was detected in all stem cells, with only a modest
upregulation from 2i-mESCs to serum-mESCs and mEpiSCs.
Immunostaining analysis (Fig. 6B) further confirmed that both
Gjb5 and Klf4 were expressed in mESCs and their expression was
downregulated in mEpiSCs. Conversely, Sema6A expression was
upregulated in mEpiSCs. Trip6 was, on the other hand, expressed in
both pluripotent ESC stages. These results are in keeping with the
qPCR data for the cell lines and the in vivo analysis.
We next investigated whether our predictor genes could
distinguish between true naïve and primed human PSCs. By
comparing the expression levels of these genes in primed-hESCs
and their respective reverted-hESCs (Chan et al., 2013; Gafni et al.,
2013; Theunissen et al., 2014; Takashima et al., 2014) or in embryo
derived naïve-hPSCs (Guo et al., 2016) we found that some of our
genes (SPIC, KLF4, FST, DUSP6, LPAR4, JAKMIP2 and CAR14)
readily identified the three lines (Takashima, Theunissen and Guo
lines) which have been shown to align better with the pre-
implantation monkey embryo (Nakamura et al., 2016). However,
not all of our predictor genes were significantly up/downregulated
as expected in these lines (Fig. 6C). Thus, we looked at the
expression levels of these genes in published data from human pre-
implantation embryos (Blakeley et al., 2015) and found that
amongst the naïve associate-genes only GJB5 was not expressed in
the pre-implantation epiblast (Fig. S6C), suggesting that either
GJB5 is not conserved in human, or that its expression starts later in
the expanded blastocyst but prior to implantation. Of the primed-
associated genes, three (DUSP6, FST and LPAR4) are not expressed
in human pre-implantation epiblast and two (CA4 and JAKMIP2)
are expressed, but at very low levels (Fig. S6C). Interestingly, all of
these genes clearly distinguished between naïve (reset and embryo-
derived) and primed hESCs (Fig. 6C), confirming these are
conserved genes across mammalian species.
Together, these data confirm the genome-wide expression
analyses and highlight pluripotent state specific characteristics
which could be used as molecular criteria to predict the identity of
pluripotent cells in vitro.
Knockdown experiments reveal that some of the naïve/
primed ‘predictor’ genes studied affect the maintenance of
pluripotency
To discover whether the newly identified naïve- or primed-
associated genes play a role in controlling pluripotency, we
knocked down the expression of Gjb5, Scpep1 and Dusp6 in 2i-
mESCs using a combination of short-hairpin RNAs (Fig. 7). We
chose to include Dusp6 and Trip6 in this analysis because these
genes are expressed in ground state cells, albeit at lower levels than
in primed cells (Fig. 6A). 2i-mESCs were efficiently transduced
(Fig. 7A) and gene knockdown was confirmed by PCR analysis
72 h after (Fig. S7A). Knockdown of Gjb5, Scpep1 or Dusp6, but
not of Trip6, led to perturbation of the pluripotent state as
demonstrated by the reduced expression of SSEA1 (Fig. 7B).
Reduced expression of Oct4 and Sox2 was also observed both at the
RNA and protein level when the naïve-associated gene Gjb5 was
knocked down (Fig. 7B; Fig. S7A) and wewere unable to establish a
knockdown cell (KD-cell) line from these cells as they had impaired
proliferation capacity (data not shown). In contrast to the other genes
tested (Scpep1, Dusp6 and Trip6), the Gjb5 knockdown cells
quickly lost the KD-viruses and the associated knockdown of Gjb5
over passaging (Fig. 7C; Fig. S7B), suggesting that the lowly/non-
transduced cells take over the culture during prolonged culture.
Interestingly, knockdown of the naïve-primed transition-associated
geneDusp6 also led to the downregulation ofNanog,Oct4 and Sox2
RNA expression as well as Oct4 and Sox2 protein levels (Fig. 7B;
Fig. S7A). Surprisingly, we were able to maintain a Dusp6 KD-cell
line and it grossly retained the phenotype observed at 72 h, except
for a moderate increase in the expression levels ofGjb5 and Scpep1,
Fig. 5. In vivo/in vitro comparison underpinned relevant naïve and
primed pluripotency-associated genes. (A) Heatmap of the conservation
of differentially expressed genes between in vivo and in vitro samples. The
overlap is expressed for genes that are differentially expressed in mouse
(left) and for genes whose differential expression is conserved among the
three species (right). Log-fold changes are shown with respect to a
randomised control, as in Fig. 4C. P-values are based on the
hypergeometric distribution, **P<1E-4, *P<0.01. (B) Venn diagrams showing
the intersections between the sets of differentially expressed genes in 2i-
mESCs versus mEpiSCs and our dataset of common differentially
expressed genes across species (ICM versus ERSE or APE). (C) RT-qPCR
showing the expression of some of the newly discovered pluripotency-
associated genes in bovine, porcine and mouse embryos: isolated ICM (for
mouse only), whole blastocyst, ERSE and APE. Expression values are
normalised against Gapdh (blue, Sus; red, Bos; green, Mus). Three
independent biological replicates were analysed. Error bars represent the
standard deviation. (D) Immunostaining of Gjb5, Trip6 and Sema6a together
with Oct4 in mouse blastocysts and ERSE stage embryos. DAPI staining is
shown in blue. Right panels indexed with a ‘P’ represent the maximum
projection of the z-stacks for the ERSE embryos. Three to four independent
embryos were analysed and these are representative embryos.
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confirming its role upstream ofOct4 and Sox2 expression (Fig. 7C).
The Scpep1 knockdown did not interfere with the expression of the
core pluripotency genes (Fig. 7B; Fig. S7A), suggesting that, unlike
Gjb5 and Dusp6, this gene is not involved in the core pluripotency
circuitry. We were able to establish a KD-cell line from Scpep1
knockdown cells and these retained the same phenotype observed at
72 h post-transduction (Fig. 7C). However, like the Gjb5 KD-cells,
these cells proliferated much slower than wild-type cells or the
scramble control cells (data not shown). Lastly, the knockdown of
Trip6 showed reduced protein levels of Nanog, Oct4 and Sox2
which, intriguingly, was not reflected at the RNA level (Fig. 7B;
Fig. S7A), suggestive of posttranscriptional modulation of
pluripotency factor expression. Trip6 KD-cells were established
successfully and proliferated normally. Of note was the fact this line
expressed higher levels of Oct4, Sox2, Klf4, Gjb5 and Scpep1,
which suggests that despite an initial destabilisation of the
pluripotent state (lower levels of Oct4, Sox2 and Nanog at the
protein level), this line progressively stabilised in a ‘higher-naïve’
state (Fig. 7C).
Given the phenotype of the Dusp6 and Trip6 KDs in 2i-mESCs,
we also determined if these genes impacted on pluripotency in
mEpiSCs where they are expressed at higher levels (Fig. S7C). We
found that the KD of bothDusp6 and Trip6 lead to differentiation as
determined by the higher levels of Sox2, Bra and Foxa2. This was
accompanied by a very modest decrease of Nanog and Oct4 in the
Dusp6 KD, which could reflect the fact we only obtained a low level
of KD (40% KD) in these cells and suggests that differentiation in
the mEpiSCs Dusp6-KD is likely due to increased levels of FGF/
ERK as it is already known that Dusp6 counteracts ERK signalling
(Yang et al., 2012).
In conclusion, at least some of the genes discovered through our
analysis play a role in maintaining pluripotency. Interestingly,
Dusp6’s role in pluripotency is not restricted to the pluripotency
state it is mainly associated with, but this is not so surprising given
that this gene is not exclusively expressed in the primed state.
Moreover, in mESCs, the absence of the naïve-prime transition gene
Trip6 appears to promote a ‘higher-naïve’ state of pluripotency,
suggesting a link between Trip6 levels of expression and the naïve
to primed transition.
DISCUSSION
Here we compare the transcriptomes of pre-implantation and early
post-implantation embryos of bovine, porcine and murine embryos,
with the aim of elucidating the molecular basis of pluripotency
within these embryos and the extent of conservation of stem cell
gene expression patterns between corresponding embryonic stages.
We used 1:1:1 orthologues in the analysis to focus on conserved
traits and thus identify the cross-species molecular signature for
naïve and primed pluripotency. This reductionist approach allowed
us to identify with great confidence a small set of molecular
determinants for each pluripotent state. We also identified
divergences across species. These are likely underestimated
because, by focusing on orthologue genes, we ignored genes
which have related genes in the different species. Thus, more work
needs to be performed to address the inter-species divergences with
the aim of explaining differences in stem cell isolation and
properties between ungulates and mice.
ICM to ERSE transition reflects the pluripotent state
transition in mammalian development
Our analysis showed that the ICM to ERSE transition is most
critical, while the changes taking place between the ERSE and APE
stage are either less dramatic or less conserved. Analysis of monkey
embryo development highlighted a similar trend where the early to
late post-implantation epiblast transition revealed few changes in
gene expression (Nakamura et al., 2016). This may underlie the fact
that the ICM to ERSE transition is characterised by both the
segregation of the primitive endoderm from the epiblast and the
conversion from a naïve to a primed pluripotency state (Nichols and
Smith, 2009; Brons et al., 2007; Tesar et al., 2007). Conservation of
such processes across mammals is strongly indicated by the
presence, among the commonly downregulated (ICM-to-ERSE)
genes, of some naïve pluripotency genes such as Tfcp2l1, Klf4 and
Klf5, and others expressed in the primitive endoderm in the mouse
such as Pdgfra, Gata6 and Sdc4. The similarities seen within ERSE
and APE stages may also suggest that embryos at these stages are
already within the phylotypic stage of embryo development and, as
per the hourglass model of embryonic evolution (Varlet et al.,
1997), that would indicate that while the ICM stage represents the
early most divergent part of the hourglass, the ERSE/APE stage
represents the beginning of the ‘narrowing’ part of the hourglass.
New naïve and primed pluripotency predictor genes were
identified
By comparing our in vivo data with the expression data for mouse
pluripotent stem cell lines, we identified a set of pluripotency
predictor genes of which at least some are important for
pluripotency maintenance. It was reassuring to find known
pluripotency-associated genes, Klf4 and Lin28b, among the
differentially expressed gene set. Klf4 has been previously shown
to be activated downstream of the LIF/STAT pathway to induce
mESC self-renewal, for restoring naïve pluripotency in EpiSCs
(Guo et al., 2009; Hall et al., 2009) and to be required for
reprogramming of mouse iPSCs (Wei et al., 2009). LIN28B has also
been used for reprogramming but, unlike Klf4, it was used to
reprogram hiPSCs (Yu et al., 2007), which bear more resemblances
to mEpiSCs (Brons et al., 2007; Tesar et al., 2007). Furthermore,
Lin28B has been shown to be a negative regulator of the
differentiation-promoting Let7 miRNAs, which are upregulated in
mEpiSCs (Jouneau et al., 2012; Viswanathan et al., 2008).
Interestingly, Lin28b expression has only been described in vivo
in pre-implantation mouse embryos (Vogt et al., 2012). Here, we
confirmed its expression in murine blastocyst cells but also
identified it as being upregulated in murine, bovine and porcine
ERSE and APE stage epiblasts.
Other genes highlighted by our analysis have been described as
pluripotency-associated genes, but their role in the pluripotency
circuitry has not been determined. Amongst those is Dusp6, a gene
Fig. 6. Common in vivo naïve and primed pluripotency-associated
genes also distinguish naïve and primed human stem cells. (A) RT-
qPCR showing the expression levels of newly discovered pluripotency-
associated genes in mouse stem cells (2i-mESCs or serum-mESCs;
mEpiSCs; mTSCs; mXENCs). Expression values are normalised against
Gapdh. Three independent biological replicates were analysed. Error bars
represent the standard deviation. (B) Immunostaining of Klf4, Gjb5, Trip6
and Sema6A together with Oct4 in 2i-mESCs and mEpiSCs. DAPI staining
is shown in blue. These are representative images of stained cultures. (C)
Expression of the newly discovered pluripotency-associated genes in human
conventional (primed) ESCs, human ‘reset’ (naïve) ESCs and human
embryo-derived naïve ESCs. Data were extracted from Gafni et al. (2013),
Chan et al. (2013), Theunissen et al. (2014), Takashima et al. (2014) and
Guo et al. (2016). (i) Genes associated with naïve-pluripotency. (ii) Genes
associated with primed-pluripotency, including the transition genes.
Expression values are presented in Log10 scale.
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whose expression was enriched at the ERSE/APE stages as well as
in serum-mESCs and in mEpiSCs. Dusp6 belongs to the MAP
kinase phosphatase family and was shown to restrain the activity of
Erk signalling during the early stages of differentiation (Yang et al.,
2012). Furthermore, its promoter was shown to contain a
pluripotency-specific enhancer (Zhang et al., 2009). Here we
further show that when Dusp6 is knocked down, cells differentiate
and the pluripotency circuitry is disrupted since reduced expression
of pluripotency genes is observed (Nanog, Oct4 and Sox2). As
such, Dusp6 could be considered a ‘guardian’ of pluripotency.
Another example is Trip6, a gene whose expression was enriched in
ERSE/APE stages as well as in serum-mESCs and in mEpiSCs.
Trip6 was identified previously as being part of the module of genes
which are enriched in the preimplantation epiblast and in 2i-mESCs
but not in diapause embryos (Boroviak et al., 2014). Here we further
demonstrate that Trip6 is a naïve-primed transition gene, which is
expressed moderately higher in serum-mESCs and mEpiSCs.
Interestingly, when Trip6 is knocked down in 2i-mESCs, these
cells appear to transition over passaging into a ‘higher-naïve’ state
of pluripotency, as judged by the increased levels of naïve-
associated pluripotency genes Oct4 and Sox2.
We also found conserved genes that have never been associated
with pluripotency. Amongst these, Gjb5/GJB5 and Scpep1/
SCPEP1, which are naïve-associated genes, have been linked
with the retinoic acid metabolic pathway, as has the described
pluripotency gene Klf4/KLF4 (Hatakeyama et al., 2011; Chen et al.,
2001; Shi et al., 2012). It has been reported that reprogramming of
human somatic cells to induced pluripotent stem cells can be
achieved more rapidly and efficiently by co-expressing retinoic acid
receptor gamma (Wang et al., 2011), which is amongst the genes we
found to be upregulated in vivo in APE stage embryos and in vitro in
serum-mESCs and mEpiSCs. The same study also showed that
reprogramming with retinoic acid receptor gamma induces naïve-
equivalent hiPSCs. As such, it would be of interest to further
investigate this pathway in the context of pluripotency maintenance
versus differentiation, and generically as a potential pathway
for maintaining naïve pluripotency in other species. Here we
investigated whether these genes disrupt pluripotency by
performing in vitro gene knockdowns of Scpep1 or Gjb5 and
show that the knockdown of both genes (independently) leads to
cell differentiation (SSEA1 downregulation) and to reduced
proliferation. Gjb5 in particular appears to be an important gene
within the pluripotency circuitry because it is required for normal
expression of key pluripotency genes (Oct4 and Sox2), and
maintenance of a Gjb5-KD line proved to be difficult. The
involvement of Scpep1 in pluripotency is less clear since its
knockdown does not interfere with the expression of core
pluripotency genes. It is plausible this reflects a role of Scpep1
upstream of Myc genes, which are essential for self-renewal
maintenance and do not interfere with the expression of core
pluripotency genes (Varlakhanova et al., 2010).
The physiological functions of Sema6a, Jakmip2, and of other
ERSE/APE- and mEpiSC-associated genes remain largely
unknown. These primed-pluripotency associated genes provide
markers that could be used to determine whether cultured ICMs
from non-murine species drift towards a late epiblast state. It would
therefore be very interesting to track the progression of the human
inner cell mass during embryonic stem cell derivation, similar to
what was previously done (O’Leary et al., 2012), and assess the
expression of the naïve and primed pluripotent-associated genes
identified in our study during the process of naïve or conventional
primed hESC derivation.
We used our predictor gene set as a molecular criterion to
distinguish between human naïve (reset or embryo-derived) and
primed pluripotent cells in vitro (Chan et al., 2013; Gafni et al.,
2013; Theunissen et al., 2014; Takashima et al., 2014; Guo et al.,
2016). All the predictor genes were found expressed in both type of
cells, but interestingly, only in some of the naïve human PSC lines
did our genes follow the up/downregulation trend expected. Of
note, some of our genes (SPIC, KLF4, FST, DUSP6, LPAR4,
JAKMIP2 andCAR14) readily identified the three lines (Takashima,
Theunissen and Guo lines) which have been shown to align better
with the pre-implantation monkey embryo (Nakamura et al., 2016).
We searched published human pre-implantation embryo data
(Blakeley et al., 2015) for our gene sets and found that all of the
primed associated genes (DUSP6, FST, LPAR4, JAKMIP2 and
CAR14) which distinguish between naïve and primed hESCs were
absent or expressed at very low levels in the human pre-implantation
epiblast. Remarkably, we also found that, of our naïve-associated
genes, four of them are expressed in the human blastocyst (SPIC,
KLF4, PSAP and SCPEP1). However, only SPIC and KLF4 are
upregulated in naïve hESCs compared to primed hESCs, suggesting
that these naïve hESCs have stabilised in an in-between state
between the true naïve and the primed state. It has been shown using
a range of molecular assays that naïve human PSCs acquire key
features of corresponding pluripotent cells in vivo but fail to
recapitulate the embryonic context entirely (Theunissen et al.,
2016). The inappropriate up/downregulation of some of our
predictor genes in the three naïve lines which best correlate with
the monkey pre-implantation epiblast likely reflect the incomplete
reversal of primed pluripotency in these lines (or attainment of naïve
pluripotency in the case of the embryo derived naïve hESC line) but
we cannot discard the hypothesis that some of these genes are
simply not conserved in primates. We propose these (or at least
some of these) predictor genes represent a snapshot of the
developmental coordinate of pluripotency and could be used as
molecular criterion to identify naïve and primed pluripotent cells
in vitro.
Developmental stage of mouse PSCs was confirmed
By assessing the correlation of the stem cell lines with the in vivo
samples as well as looking at the expression gene trends in both
in vivo and in vitro datasets we were able to assess the developmental
position of the stem cells. For example, we found genes like Spic, of
which expression was restricted to ICM and 2i-ESCs. This indicates
that, despite the fact that 2i-mESCs do not correlate with ICM stage
embryos, they actually share some traits with ICM cells. This was
further confirmed by the global correlation and evolutionary
conservation analysis of the data. In sum, our findings suggest that
the ‘developmental position’ of 2i-mESCs is in between the ICM and
ERSE stage epiblast, while serum-ESCs closely resemble the ERSE
Fig. 7. Pluripotency stability is affected after knocking down some
newly identified conserved genes. (A) Confocal micrographs of mESCs
72 h after transduction showing the levels of GFP+ transduced cells. These
are representative results of three biological replicates. (B) Flow cytometry
plots showing the levels of pluripotency gene expression in KD mESCs.
Median is highlighted for the sample analysed and the respective IgG control
is presented in a dashed line. These are representative results of three
biological replicates. (C) RT-qPCR showing the expression levels of core
pluripotency genes and newly discovered pluripotency-associated genes in
knockdown and control scramble transduced mESCs after six to eight
passages in 3 μg puromycin. Expression values are normalised against
Gapdh. Three independent biological replicates were analysed. Error bars
represent the standard deviation.
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stage epiblast, which is in keeping with what has been proposed by
others (Chen et al., 2016; Boroviak et al., 2014). The ‘developmental
position’ of mEpiSCs was less obvious as these cells grouped closely
with both pre-gastrulating (ERSE) and early gastrula epiblast cells
(APE). However, we observed that there were more genes
upregulated in mEpiSCs which were uniquely upregulated in APE
stage embryos (rather than those upregulated in ERSE stage embryos)
suggesting that, in keeping with Kojima et al., mEpiSCs are
developmentally more similar to gastrula-stage embryos (Kojima
et al., 2014). This observation differs fromwhat has been proposed by
Chen et al. which placed mEpiSCs closer to the E5.5 pre-gastrulation
stage embryo (Chen et al., 2016).
Conclusions and future directions
Collectively, the molecular changes we observed in the embryo
datasets allowed us to identify: (1) conserved new predictor genes
representing a snapshot of the developmental coordinate of
pluripotency in mammals (Fig. 8) and which could be used as
molecular criteria to identify naïve and primed pluripotent cells in
vitro; (2) various differences between mouse and ungulate species,
regarding the timing of expression of pluripotency markers and
signalling effectors and (3) several characteristics of the current ESC
systems that are not present in their in vivo counterparts. Importantly,
we confirmed that while some of our newly identified pluripotency
genes play a role in pluripotency in vitro, other candidates remain to be
studied and could potentially also play important roles in pluripotency.
Our dataset could further be used to identify additional cross-species
divergences with the aim of trying to circumvent the issues associated
with the generation of ESCs from refractory species. Furthermore,
understanding the culture adaptations ESC systems undergo in vitro is
crucial for the efficacy and safety of cell therapies.
MATERIALS AND METHODS
Mouse ESC and EpiSC culture
129S2/SvPas and F1 (C57Bl/6JxDBA/2J) mouse ESCs were derived as
previously described and cultured using standard protocols (Nagy, 2003).
Corresponding 129S2/SvPas and F1 mouse EpiSCs were cultured using
standard protocols (Brons et al., 2007). All lines were validated in-house and
tested for contaminants. For more details see Supplemental experimental
procedures.
Embryo sample preparation
Both hybrid (B6D2F1) and inbred (129S2) mouse embryos (sex not
determined) were used. Pre-implantation mouse samples (ICM stage,
E3.5) were collected by flushing the embryos out of the uterus.
Fig. 8. Proposed model of the developmental timeline of naïve and primed pluripotency in mouse and ungulate species.
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Post-implantation stage mouse epiblasts were dissected as described
(Nagy, 2003) at two time points: at pre-gastrulation stage (ERSE stage,
E6.25) and at mid-gastrulation stage (APE stage, E7.25). For details see
Supplemental experimental procedures.
Pig embryos (sex not determined) were obtained by breeding Danish
Landrace females and Yorkshire males after induced oestrus by weaning.
Embryos at E7-E8 (ICM stage), E10-E11 (ERSE stage) and E12-E13
(APE stage) were collected from the uterine horns (for stages E7-E8 and
E12-E13) or by manually clipping open the uterine horns for gentle
floating off the embryos (E10-E11). For details see Supplemental
experimental procedures.
For bovine embryos (sex not determined), ICM stage blastocysts (E7)
were obtained after in vitro maturation/fertilisation of oocytes and cultured
using standard procedures. The ICMwas isolated using immunosurgery. To
obtain later stages, donor cows were bred by artificial insemination after
induced oestrus and super-ovulation. Embryos at E14 (ERSE stage) and at
E17 (APE stage) were collected non-surgically by gentle flushing. For
details see Supplemental experimental procedures.
mRNA preparation, cDNA synthesis and sequencing
Pure epiblasts or ICM were harvested into TriZol and snap frozen. RNA
was isolated using the PureLink™ RNA Micro Kit (Invitrogen). cDNA
was prepared for RTqPCR using superscript III (Invitrogen); or for
sequencing using either 100 pg of RNA and following the SMARTer
(Illumina, San Diego, USA), Spia-Ovation (NuGEN, Leek, The
Netherlands) or oligo dT [adapted from (Kurimoto et al., 2006)]
method, or using 1 μg RNA and following the standard random hexamer
method from Illumina. The samples were sequenced using an Illumina
HiSeq2000. All RNA-seq (FASTQ and BedGraph files) are present in
the NCBI GEO SuperSeries GSE53387. For details, see Table S1 and
Supplemental experimental procedures.
Bioinformatic analysis
Details of the bioinformatic analysis performed are described in the
Supplemental experimental procedures.
Real time PCR
Quantitative polymerase chain reactions (q-PCR) were performed in triplicates
using SYBR Green ReadyMix (Roche Products Limited, Welwyn Garden
City, UK or Applied Biosytems, Foster City, USA) and the results were
normalised to the house keeping gene Gapdh/GAPDH as internal reference
(primers supplied by Sigma-Aldrich). For more details, see Supplemental
experimental procedures.
In situ hybridisation
Embryos were fixed in 4% paraformaldehyde (PFA; Sigma-Aldrich),
dehydrated and stored in methanol 100% at −20°C until further processing.
For whole-mount ISH, samples were rehydrated, and processed using a
standard protocol. For details, see Supplemental experimental procedures.
Immunohistochemistry
Mouse embryos, mESCs and mEpiSCs were fixed in 4% (w/v) PFA and
immunostained using a standard protocol. For details on antibodies see
Supplemental experimental procedures.
Transduction experiments
2i-mESCs were transduced with sh-RNAs expressing lentiviruses. A control
GFP expressing lentivirus was used to test for transduction efficiency. Cells
were harvested 72 h after transduction.
Flow cytometry
Cell suspensions were fixed and stained using the Cytofix-Cytoperm kit
(BD Biosciences) and following manufacturer’s instructions as described in
Supplemental experimental procedures. Cells were analysed using a
Beckman Coulter CyAnADP flow cytometer and FlowJo software (Becton
Dickinson, Franklin Lake, USA).
Accession numbers
All RNA-seq (FASTQ and BedGraph files) are present in the NCBI GEO
SuperSeries GSE53387.
Other datasets used
RNA-seq data for three ESC lines cultured in 2i+Lif and three ESC lines
cultured in serum+Lif were obtained from Marks et al. (2012). RNA-seq
data for three EpiSCs lines were from Veillard et al. (2014).
Acknowledgements
We thank Dr Yan Tan for assistance in preparing libraries for sequencing;
Dr Thomas Spruce for his advice and support in collecting mouse embryos;
Christophe Richard for the bovine embryo collections and Vincent Brochard for help
with the in situ hybridisations. We also thank Dr Kathy Niakan for providing samples
of mXENCs RNA as well as for helpful discussions and Hayley Wood in the
Photographics Department at the Francis Crick Institute for her help with Illustrator.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualisation: A.S.B., A.J., M.H., R.A.P., A.D.; Methodology: A.S.B., H.M., P.K.,
T.F., H.H.K., K.M., M.H.; Software: H.M., P.K., H.H.D.K., K.M., M.H.; Validation:
A.S.B., A.J., J.K., K.F., V.H., C.B., G.P.; Formal analysis: A.J., H.M., P.K., H.H.D.K.,
K.M., M.H.; Investigation: A.S.B., A.J., J.K., K.F., V.H., A.F., Z.P., C.S., I.B., C.L.,
C.B., G.P., R.A.P.; Resources: A.J., J.C.S., G.L., P.H., H.G.S., M.H., R.A.P., A.D.;
Data curation: H.M., P.K., M.H.; Writing - original draft: A.S.B., A.J.; Writing - review&
editing: A.S.B., A.J., P.K., J.K., K.F., V.H., J.C.S.; Visualisation: A.S.B., P.K.;
Supervision: A.S.B., A.J., H.M., J.C.S., G.L., P.H., H.G.S., M.H., R.A.P., A.D.;
Project administration: A.S.B., A.D.; Funding acquisition: A.J., G.L., P.H., H.G.S.,
R.A.P., A.D.
Funding
This work was supported by the Seventh Framework Programme (EU FP7) projects:
PluriSys, HEALTH-2007-B-223485; EPIHEALTH, HEALTH-2012-F2-278418;
EpiHealthNet, PITN-GA-2012-317146; PartnErS, PIAP-GA-2008-218205;
ANISTEM, PIAPP-GA-2011-286264; STEMMAD, PIAPP-GA-2012-324451;
RabPStem, PERG07-GA-2010-268422; Epiconcept, COST Action FA1201 and
NKTH/KPI Bonus Plurisys, OMFB-00236/2010. Support was also received from the
Danish Council for Independent Research, Natural Sciences (FNU), grant number:
11-106627. A.S.B. was supported by PluriSys, HEALTH-2007-B-223485, and by the
British Heart Foundation (FS/12/37/29516). H.M. is supported by a grant from the
Netherlands Organization for Scientific Research (NWO-VIDI 864.12.007). A.J. is
supported by ANR Programme Investissements d’Avenir REVIVE. J.C.S. was
supported by the Medical Research Council (program number U117597140) and is
now supported by the Francis Crick Institute, which receives its core funding from
Cancer Research UK (FC001157), the UK Medical Research Council (FC001157)
and the Wellcome Trust (FC001157).
Supplementary information
Supplementary information available online at
http://bio.biologists.org/lookup/doi/10.1242/bio.033282.supplemental\
References
Alberio, R., Croxall, N. and Allegrucci, C. (2010). Pig epiblast stem cells depend
on activin/nodal signaling for pluripotency and self-renewal. Stem Cells Dev. 19,
1627-1636.
Artus, J., Panthier, J. J. and Hadjantonakis, A. K. (2010). A role for PDGF
signaling in expansion of the extra-embryonic endoderm lineage of the mouse
blastocyst. Development 137, 3361-3372.
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N. and Lovell-Badge,
R. (2003). Multipotent cell lineages in early mouse development depend on SOX2
function. Genes Dev. 17, 126-140.
Blakeley, P., Fogarty, N. M. E., Del Valle, I., Wamaitha, S. E., Hu, T. X., Elder, K.,
Snell, P., Christie, L., Robson, P. and Niakan, K. K. (2015). Defining the three
cell lineages of the human blastocyst by single-cell RNA-seq. Development 142,
3151-3165.
Boroviak, T., Loos, R., Bertone, P., Smith, A. andNichols, J. (2014). The ability of
inner-cell-mass cells to self-renew as embryonic stem cells is acquired following
epiblast specification. Nat. Cell Biol. 16, 513-525.
Bourillot, P. Y., Aksoy, I., Schreiber, V., Wianny, F., Schulz, H., Hummel, O.,
Hubner, N. and Savatier, P. (2009). Novel STAT3 target genes exert distinct roles
in the inhibition of mesoderm and endoderm differentiation in cooperation with
Nanog. Stem Cells 27, 1760-1771.
15
RESEARCH ARTICLE Biology Open (2018) 7, bio033282. doi:10.1242/bio.033282
B
io
lo
g
y
O
p
en
 by guest on October 21, 2018http://bio.biologists.org/Downloaded from 
Brons, I. G., Smithers, L. E., Trotter, M.W. B., Rugg-Gunn, P., Sun, B., Chuva De
Sousa Lopes, S. M., Howlett, S. K., Clarkson, A., Ahrlund-Richter, L.,
Pedersen, R. A. et al. (2007). Derivation of pluripotent epiblast stem cells from
mammalian embryos. Nature 448, 191-195.
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and
Smith, A. (2003). Functional expression cloning of Nanog, a pluripotency
sustaining factor in embryonic stem cells. Cell 113, 643-655.
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